Mangalam Drugs And Organics Limited — Board Meeting, 15-01-2026: Outcome of Board Meeting
15-01-2026 | 05:37 pm
15-01-2026 | 05:37 pm
Mangalam Drugs' board approved the consolidated financial results for the quarter and nine months ended Dec 31, 2025, showing a net loss of ₹9.84 Cr on sales of ₹58.38 Cr. The CFO and Company Secretary also resigned, effective Jan 31 and Mar 29, 2026, respectively.
No comments yet. Be the first to comment!
